CNE100000GY2
CNE100000GY2
ANKEBIO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.646.519.768 | 2.536.042.782 | 4.4% |
| Cost of Revenue | 643.158.186 | 573.308.673 | 12.2% |
| Gross Profit | 2.003.361.582 | 1.962.734.108 | 2.1% |
| 1.162.203.866 | 1.168.205.069 | 0.5% | |
| Operating Income | 841.157.716 | 794.529.040 | 5.9% |
| Pretax Income | 833.158.101 | 803.016.703 | 3.8% |
| Net Income Common Stockholders | 735.192.706 | 706.948.364 | 4.0% |
| -- | -- | -- | |
| -- | -- | -- |